Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss - Quiz - MDSpire

Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss

  • By

  • Yuan Chen

  • Yue Ba

  • Meiling Sun

  • Jun Hu

  • Qin Jiang

  • Bin Liu

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss

  • by Yuan Chen, Yue Ba, Meiling Sun, Jun Hu, Qin Jiang, Bin Liu

  • July 1, 2026

Related Content

JAMA Otolaryngology–Head & Neck Surgery —The Year in Review, 2025

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.

Systems perspectives on pediatric otitis media: environmental exposures, genetic susceptibility, and biomarker-guided interventions